Scientific work

Doç. Dr. İlkay Gültürk

52 publications. The source of the information is stated next to each publication.

Back to profile

  1. Bone Pain Is Associated with Short Radiographic Progression-Free Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15103968 PMID 42194929 Open-access full textSource: OpenAlex

  2. Association between obesity and outcomes of first-line CDK4/6 inhibitor therapy in metastatic breast cancer: a multicenter real-world study

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-58205-7 PMID 42304044 Open-access full textSource: OpenAlex

  3. Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy

    Cancers, 2026

    DOI 10.3390/cancers18142302 PMID 42512369 Open-access full textSource: ORCID

  4. Kaposi Sarcoma Presenting as Hemophagocytic Lymphohistiocytosis Mimicking Infection and Lymphoma: A Diagnostic Challenge

    Cureus, 2026

    DOI 10.7759/cureus.105780 PMID 42037832 Open-access full textSource: OpenAlex

  5. The Clinical Significance of Gallium‐68 PSMA‐11 PET‐Derived SUVmax in the Management of Metastatic Hormone‐Sensitive Prostate Cancer

    The Prostate, 2026

    DOI 10.1002/pros.70185 PMID 42018584 Open-access full textSource: ORCID

  6. Bone Pain Is Associated with Short Radiologic-Progression-Free Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer

    2026

    DOI 10.20944/preprints202604.1309.v1 Open-access full textSource: ORCID

  7. Association of Pretreatment IronMLR and ANR With Pathological Response Following Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

    SSRN Electronic Journal, 2026

    DOI 10.2139/ssrn.7100220 Open-access full textSource: ORCID

  8. Association of Pretreatment ANR and IronMLR With Pathological Response Following Neoadjuvant Chemotherapy in Breast Cancer

    Breast Cancer Targets and Therapy, 2026

    DOI 10.2147/bctt.s623894 PMID 42677318 Open-access full textSource: OpenAlex

  9. A multi-center case-control study on osteoporosis risk in cancer patients receiving chemotherapy.

    Journal of Clinical Oncology, 2025

    DOI 10.1200/jco.2025.43.16_suppl.12033 Source: OpenAlex

  10. A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy

    Supportive Care in Cancer, 2025

    DOI 10.1007/s00520-025-09973-x PMID 41225034 1 citation (Europe PMC) Source: OpenAlex

  11. Very deep prostate-specific antigen decline is associated with longer rPFS in patients with metastatic castration-sensitive prostate cancer

    Therapeutic Advances in Medical Oncology, 2025

    DOI 10.1177/17588359251369037 PMID 40895017 Open-access full textSource: OpenAlex

  12. Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-96157-6 PMID 40188172 8 citations (Europe PMC) Open-access full textSource: OpenAlex

  13. The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors

    Cancers, 2025

    DOI 10.3390/cancers17040693 PMID 40002286 14 citations (Europe PMC) Open-access full textSource: OpenAlex

  14. Evaluation of Dose Reduction Factors and Impact on Progression-Free Survival in Patients Treated with CDK 4/6 Inhibitors

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14041071 PMID 40004601 9 citations (Europe PMC) Open-access full textSource: OpenAlex

  15. Prognostic Importance of PTEN and P53 in Aggressive Luminal A Subtype Breast Cancers

    European journal of breast health, 2025

    DOI 10.4274/ejbh.galenos.2025.2025-2-12 PMID 40390381 2 citations (Europe PMC) Open-access full textSource: Europe PMC

  16. The Relationship Between Changes in the Neutrophil-Lymphocyte Ratio (NLR) and Radiological Progression in Cervical Cancer

    Istanbul Medical Journal, 2025

    DOI 10.4274/imj.galenos.2025.59254 Open-access full textSource: OpenAlex

  17. 18F-FDG PET/CT Findings Mimicking Gallbladder Metastasis From a Rectal Adenocarcinoma: Rare Synchronous Gallbladder and Rectal Cancer

    Clinical Nuclear Medicine, 2025

    DOI 10.1097/rlu.0000000000005812 PMID 40029796 Source: OpenAlex

  18. The impact of sarcopenia on adverse effects and survival in patients with metastatic hormone receptor-positive breast cancer treated with CDK4/6 inhibitors

    Medicine, 2025

    DOI 10.1097/md.0000000000043374 PMID 40660511 Open-access full textSource: ORCID

  19. The Prognostic Value of the EASIX Score in Patients with Metastatic Pancreatic Cancer

    Diagnostics, 2025

    DOI 10.3390/diagnostics15141740 PMID 40722492 2 citations (Europe PMC) Open-access full textSource: ORCID

  20. 68Ga PSMA PET/CT and 18F FDG PET/CT Findings in Osteonecrosis of the Jaw Induced by Denosumab

    Clinical Nuclear Medicine, 2025

    DOI 10.1097/rlu.0000000000005751 PMID 40025661 5 citations (OpenAlex) Source: OpenAlex

  21. The relationship between body mass index and survival in patients with renal cell carcinoma treated with nivolumab

    Journal of Chemotherapy, 2025

    DOI 10.1080/1120009x.2025.2469371 PMID 39988757 2 citations (OpenAlex) Source: OpenAlex

  22. The Role of Magnetic Resonance Imaging in Predicting Pathological Complete Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

    Bagcilar Medical Bulletin, 2025

    DOI 10.4274/bmb.galenos.2025.33042 Open-access full textSource: OpenAlex

  23. Evaluación de la eficacia del tratamiento según los criterios RECIP 1.0 en el cáncer de próstata sensible a la castración

    Actas Urológicas Españolas, 2025

    DOI 10.1016/j.acuro.2025.501837 Source: OpenAlex

  24. Evaluation of treatment efficacy according to RECIP 1.0 criteria in castration-sensitive prostate cancer

    Actas Urológicas Españolas (English Edition), 2025

    DOI 10.1016/j.acuroe.2025.501837 PMID 40939837 Source: OpenAlex

  25. 2407P Elevated SUVmax on gallium-68-PSMA-11 PET (PSMA-PET) is associated with shorter radiographic progression-free survival (rPFS) in patients with metastatic castration-sensitive prostate cancer (mCSPC)

    Annals of Oncology, 2025

    DOI 10.1016/j.annonc.2025.08.3023 Open-access full textSource: OpenAlex

  26. Relationship of Neoadjuvant Chemotherapy Efficacy with Histopathologic Molecular Subtypes in Breast Cancer Patients

    Istanbul Medical Journal, 2024

    DOI 10.4274/imj.galenos.2024.96266 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  27. Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function

    Actas Urológicas Españolas (English Edition), 2024

    DOI 10.1016/j.acuroe.2024.04.002 PMID 38570033 Source: OpenAlex

  28. The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study

    Breast Cancer Research and Treatment, 2024

    DOI 10.1007/s10549-024-07291-0 PMID 38526689 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  29. Could macrocytosis predict survival In advanced breast cancer patients that were treated with CDK 4–6 inhibitors?

    The Breast, 2024

    DOI 10.1016/j.breast.2024.103820 PMID 39405594 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  30. Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes

    Cancers, 2024

    DOI 10.3390/cancers16223880 PMID 39594835 8 citations (Europe PMC) Open-access full textSource: ORCID

  31. The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-75293-5 PMID 39384975 1 citation (Europe PMC) Open-access full textSource: ORCID

  32. Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer

    Journal of College of Physicians And Surgeons Pakistan, 2024

    DOI 10.29271/jcpsp.2024.01.37 PMID 38185958 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  33. Assessment of Oral Capecitabine in Elderly Patients with Stage 2 Colon Cancer: Toxicity, Tolerability, and Survival Outcomes

    Istanbul Medical Journal, 2024

    DOI 10.4274/imj.galenos.2024.64606 Open-access full textSource: OpenAlex

  34. Comparison of Coronary Artery Calcium Score and Serum Calcium, Phosphorus, and Gamma-Glutamyl Transferase Levels in Patients with Coronary Artery Imaging by Multi-Sectional Computed Tomography with Chronic Ischemic Heart Disease Prediagnosis

    Istanbul Medical Journal, 2024

    DOI 10.4274/imj.galenos.2024.14602 1 citation (OpenAlex) Open-access full textSource: ORCID

  35. Nivolumab treatment in a patient with BRAF mutant advanced melanoma and liver failure with encephalopathy

    Journal of Oncology Pharmacy Practice, 2024

    DOI 10.1177/10781552231221230 PMID 38111303 Source: ORCID

  36. Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes

    2024

    DOI 10.20944/preprints202410.2285.v1 Open-access full textSource: ORCID

  37. Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer

    Asia-Pacific Journal of Clinical Oncology, 2024

    DOI 10.1111/ajco.14065 PMID 38572819 2 citations (OpenAlex) Source: OpenAlex

  38. Seguridad y eficacia del nivolumab para el tratamiento de pacientes con carcinoma de células renales metastásico e insuficiencia renal

    Actas Urológicas Españolas, 2024

    DOI 10.1016/j.acuro.2024.01.014 Source: OpenAlex

  39. Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy?

    Supportive Care in Cancer, 2023

    DOI 10.1007/s00520-023-07791-7 PMID 37162602 4 citations (Europe PMC) Source: ORCID

  40. Naples prognostic score may predict overall survival in metastatic pancreatic cancer

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_1392_22 PMID 38554329 12 citations (OpenAlex) Open-access full textSource: OpenAlex

  41. Naples Score May Predict Overall Survival in Metastatic Gastric Cancer and is Superior to CONUT

    Acta Oncologica Turcica, 2023

    DOI 10.5505/aot.2023.80269 Open-access full textSource: OpenAlex

  42. Partial Atrophy of The Pancreas in Endoscopic Ultrasonography may be a Sign of Pancreatic Cancer

    Istanbul Medical Journal, 2023

    DOI 10.4274/imj.galenos.2023.52386 Open-access full textSource: ORCID

  43. Temel Onkoloji

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1765 Source: OpenAlex

  44. Nivolumab induced hypophysitis in an advanced RCC patient

    Journal of Oncology Pharmacy Practice, 2022

    DOI 10.1177/10781552211072212 PMID 35006033 3 citations (OpenAlex) Source: OpenAlex

  45. With metastatic colorectal cancer: A single center experience use of monoclonal antibodies (Bevacizumab, Cetuximab, and Panitumumab) in patients

    Journal of Experimental and Clinical Medicine, 2022

    DOI 10.52142/omujecm.39.4.34 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  46. Lutetium-Associated Myopathy: A Case Report

    American Journal of Therapeutics, 2022

    DOI 10.1097/mjt.0000000000001491 PMID 35383588 1 citation (OpenAlex) Source: OpenAlex

  47. Time to Castration Resistance as a Predictor of Response to Docetaxel in Metastatic Castration Resistance in Prostate Cancer

    Istanbul Medical Journal, 2022

    DOI 10.4274/imj.galenos.2022.56804 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  48. Prosnostic Significance of Prognostic Nutrition Index in Metastatic Renal Cell Carcinoma Patients Treated with Tyrosine Kinase Inhibitors

    Namık Kemal Tıp Dergisi, 2022

    DOI 10.4274/nkmj.galenos.2022.80764 Open-access full textSource: OpenAlex

  49. Efficacy and Safety of Ombitasvir/Paritaprevir/ Ritonavir + Dasabuvir ± Ribavirin Combinations in Patients with Genotype 1 Hepatitis C and Inherited Bleeding Disorders

    The Turkish Journal of Gastroenterology, 2022

    DOI 10.5152/tjg.2022.20844 PMID 35678799 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  50. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study

    Melanoma Research, 2021

    DOI 10.1097/cmr.0000000000000744 PMID 34039945 16 citations (Europe PMC) Source: OpenAlex